In the News

Henry Waxman Ceremonially Passes Gavel to New Energy and Commerce Committee Chairman Frank Pallone

Congressman Henry Waxman ceremoniously passed the gavel to Rep. Frank Pallone, Jr., the new Chairman of the House Energy and Commerce Committee.

Henry Waxman in The Atlantic: We Must Fight For a Green New Deal

We must “show that sustainability is not just the right thing to do for the fate of our planet, but an unparalleled opportunity to ensure the prosperity of future generations.”

Waxman Strategies Adds Senior Staffers to Expand Health, Technology and Environmental Practices

Waxman Strategies today announced the addition of senior communications professionals as the firm continues to expand its technology, healthcare and environmental practices.

Waxman Strategies Welcomes Seasoned Global Policy Leaders to Environmental Practice

Waxman Strategies Welcomes Seasoned Global Policy Leaders to Environmental Practice. Mat Jacobson and Abdul Tejan-Cole bring a combined 40+ years of global campaign experience to the Waxman team.

Former Congressman Henry Waxman Provides Guidance to Democrats Anticipating White House Investigations

In the final weeks preceding the 2018 midterm elections, Waxman Strategies’ Chairman and former Congressman Henry Waxman engaged in a series of interviews to elevate the benefits behind bipartisanship and the importance of effecting a credible and comprehensive investigation.

Hatch Amendment Could Delay Generic Drug Competition and Increase Drug Prices

If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.

California Health Care Foundation Interviews Waxman Strategies Chairman Henry Waxman on the Future of Health Policy

California Health Care Foundation (CHCF) interviews  Waxman Strategies Chairman Henry Waxman on the changing political landscape of health care reform.

Analyzing the US Food and Drug Administration’s Plans to Increase Competition in Response to High Drug Prices

Prescription drug prices have reached an all-time high. FDA Commissioner Gottlieb has taken on the issue indirectly, and announced several actions by the FDA intended to increase generic drug competition and transparency.

Former Congressman Henry Waxman’s Op-Ed in the Washington Post

Democrats shouldn’t impose litmus tests on health care.

Bipartisan Deal Includes Important Step to Control Medicaid Drug Prices, But More Efforts Are Needed

Today, the Commonwealth Fund published a blog post on the Bipartisan Budget Act of 2018, which will have an impact on Medicaid drug prices.